DBV Technologies (DBVT) Shares Outstanding (2015 - 2026)

DBV Technologies (DBVT) posted Shares Outstanding (Entity) of $433.5 million for Q2 2026, up 1.22% sequentially from $428.3 million in Q1 2026, and up 216.51% YoY from $137.0 million in Q2 2025.

DBV Technologies (DBVT) Shares Outstanding (2015 - 2026) Analysis & Trends

DBV Technologies has reported Shares Outstanding (Entity) for 12 years, with the latest figure at $433.5 million in Q2 2026.

  • Quarterly Shares Outstanding (Entity) rose 216.51% year-over-year to $433.5 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $433.5 million (up 216.51% YoY) and the FY2025 annual result came in at $139.6 million, up 35.71% from the prior year.
  • Shares Outstanding (Entity) grew to $433.5 million in Q2 2026 per DBVT's latest filing, from $428.3 million in the prior quarter.
  • Over five years, Shares Outstanding (Entity) peaked at $433.5 million in Q2 2026 and troughed at $19.3 million in Q2 2024.
  • A 5-year average of $101.6 million and a median of $38.5 million in 2023 frame the typical range for Shares Outstanding (Entity).
  • The sharpest annual moves came in 2024 and 2025: Shares Outstanding (Entity) tumbled 49.87% in 2024, then surged 609.76% in 2025.
  • Over 5 years, Shares Outstanding (Entity) stood at $31.0 million in 2022, then gained by 24.61% to $38.6 million in 2023, then soared by 166.63% to $102.8 million in 2024, then surged by 35.71% to $139.6 million in 2025, then jumped by 210.61% to $433.5 million in 2026.
  • According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $433.5 million, $428.3 million, and $139.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 253.70 Mn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 102.80 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 62.19 Mn
4 Revolution Medicines 43.64 Bn 43.64 Bn - 210.89 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 1.45 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 25.05 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn - 445.06 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 133.61 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 217.35 Mn
10 DBV Technologies 6.08 Bn 5.90 Bn - 433.54 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 433.54 Mn
Mar 31, 2026 428.30 Mn
Dec 31, 2025 139.57 Mn
Sep 30, 2025 136.81 Mn
Jun 30, 2025 134.48 Mn
Mar 31, 2025 102.62 Mn
Dec 31, 2024 97.00 Mn
Sep 30, 2024 19.24 Mn
Jun 30, 2024 19.23 Mn
Mar 31, 2024 38.47 Mn
Dec 31, 2023 38.05 Mn
Sep 30, 2023 38.43 Mn
Jun 30, 2023 37.73 Mn
Mar 31, 2023 37.59 Mn
Dec 31, 2022 30.95 Mn
Sep 30, 2022 37.56 Mn
Jun 30, 2022 26.42 Mn
Mar 31, 2022 21.97 Mn
Dec 31, 2021 21.97 Mn
Sep 30, 2021 21.98 Mn